Translating molecular advances in Down syndrome and Fragile X syndrome into therapies
Sign Up to like & getrecommendations! Published in 2018 at "European Neuropsychopharmacology"
DOI: 10.1016/j.euroneuro.2018.03.006
Abstract: Ongoing treatments for genetic developmental disorders of the central nervous system are mostly symptomatic and do not correct the genetic cause. Recent identification of common mechanisms between diseases has suggested that new therapeutic targets could… read more here.
Keywords: advances syndrome; common mechanisms; fragile syndrome; molecular advances ... See more keywords
Molecular Advances in Central Nervous System Mesenchymal Tumors.
Sign Up to like & getrecommendations! Published in 2020 at "Surgical pathology clinics"
DOI: 10.1016/j.path.2020.02.002
Abstract: Mesenchymal tumors of the central nervous system (CNS) comprise an array of neoplasms that may arise from or secondarily affect the CNS and its immediate surroundings. This review focuses on meningiomas and solitary fibrous tumors,… read more here.
Keywords: advances central; nervous system; central nervous; molecular advances ... See more keywords
Revisiting biodiscovery from microbial sources in the light of molecular advances
Sign Up to like & getrecommendations! Published in 2017 at "Microbiology Australia"
DOI: 10.1071/ma17028
Abstract: Since thediscovery of penicillinmicroorganismshave been an unexhausted source of novel bioactive compounds that served as scaffolds for potential drug candidates as well for the development of new antibiotics via fermentative processes. However, after 30 glorious… read more here.
Keywords: revisiting biodiscovery; biodiscovery microbial; light molecular; molecular advances ... See more keywords
Recent Clinical and Molecular Advances for the Classification of Myelodysplastic Neoplasms.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of the National Comprehensive Cancer Network : JNCCN"
DOI: 10.6004/jnccn.2022.7088
Abstract: Several major updates have recently occurred for the NCCN Guidelines for Myelodysplastic Syndromes (MDS) based on a number of prominent articles that have particular clinical and biologic impact for the field. These changes, which have… read more here.
Keywords: classification; molecular advances; advances classification; classification myelodysplastic ... See more keywords